Devices › Device types
FDA product code MCW · class 2 · Cardiovascular
Catheter, peripheral, atherectomy: medical device reports filed with FDA
8,514 reports carry this product code, 1994–2026; 19 brands with a page.
- 8,514
- reports with this product code
- 0% of all MAUDE reports
- 904
- reports, 12 months to August 2026
- 676 in the 12 months before
- 55.6%
- classified as malfunction
- 62.3% across all reports
- 1.8%
- classified as death, as reported
- 0.9% across all reports
Product code MCW is FDA's classification for "Catheter, peripheral, atherectomy" (cardiovascular panel), a class 2 device. 8,514 medical device reports carry this product code, 0% of the MAUDE database, from January 1994 to August 2026.
904 reports arrived in the 12 months to August 2026, up 34% from 676 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (55.6%), injury (40.9%) and death (1.8%). 19 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Rotarex | 1,331 | 373 | 0.7% | 84.6% |
| JETSTREAM XC Atherectomy Catheter | 741 | 71 | 0.3% | 79.2% |
| Diamondback 360 Peripheral Orbital Atherectomy System | 672 | 0 | 0.9% | 21.3% |
| Jetstream Xc | 590 | 44 | 0% | 89.3% |
| Hawkone 6fr | 566 | 30 | 0% | 71.9% |
| Diamondback 360 Orbital Atherectomy System | 239 | 0 | 3.3% | 4.6% |
| Peripheral Rotalink Plus | 158 | 1 | 1.9% | 74.7% |
| JETSTREAM Atherectomy Catheter | 151 | 32 | 0.7% | 27.8% |
| Crosser Recanalization Catheter | 16 | 0 | 1.3% | 81.8% |
| Rotalink Catheter | 12 | 0 | 13% | 35.7% |
| Diamondback 360 Coronary Orbital Atherectomy System | 10 | 0 | 15.7% | 8.1% |
| Crosser Cto Recanalization Catheter | 9 | 0 | 0.3% | 92% |
| Fogarty Arterial Embolectomy Catheter | 4 | 37 | 0.2% | 87.4% |
| Rotablator Guide Wire | 2 | 0 | 3.7% | 55.7% |
| Crosser Cto Recanalization Catheters | 1 | 0 | 0% | 93.7% |
| Datascope | 1 | 0 | 7.3% | 40.2% |
| Diamondback Coronary | 1 | 222 | 15.9% | 19.5% |
| RotaLink? Plus | 1 | 42 | 4.4% | 69.7% |
| Trapease Filter | 1 | 0 | 13.9% | 11.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Cardiovascular Systems | 1,571 | 18.5% |
| Straub Medical | 940 | 11% |
| Medtronic Ireland | 873 | 10.3% |
| Spectranetics | 322 | 3.8% |
| Ev3 | 301 | 3.5% |
| Boston Scientific - Cork | 248 | 2.9% |
| Boston Scientific - Maple Grove | 207 | 2.4% |
| The Spectranetics | 135 | 1.6% |
| Covidien Irvine | 115 | 1.4% |
| Bard Peripheral Vascular | 47 | 0.6% |
| Boston Scientific | 43 | 0.5% |
| Boston Scientific - Costa Rica Heredia | 25 | 0.3% |
| Arrow Intl | 24 | 0.3% |
| Guidant Vascular Intervention | 8 | 0.1% |
| Boston Scientific - Fremont Ce | 7 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 1,326 | 15.6% |
| Detachment of device or device componentpart of the device came off | 1,120 | 13.2% |
| Entrapment of device | 1,039 | 12.2% |
| Material separation | 665 | 7.8% |
| Difficult to removethe device was hard to remove | 602 | 7.1% |
| Material deformation | 556 | 6.5% |
| Mechanical jam | 442 | 5.2% |
| Physical resistance/sticking | 324 | 3.8% |
| Mechanical problema mechanical problem | 262 | 3.1% |
| Fracturea broken bone | 240 | 2.8% |
| Suction problem | 200 | 2.3% |
| Sticking | 196 | 2.3% |
| Detachment of device component | 194 | 2.3% |
| Difficult to advance | 170 | 2% |
| Noise, audible | 158 | 1.9% |
| Failure to advance | 155 | 1.8% |
| Device damaged by another device | 153 | 1.8% |
| Insufficient device problem information | 153 | 1.8% |
| Device operates differently than expectedthe device behaved unexpectedly | 125 | 1.5% |
| Aspiration issue | 124 | 1.5% |
Questions about catheter, peripheral, atherectomy reports
What is product code MCW?
FDA's classification code for "Catheter, peripheral, atherectomy", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
8,514 reports through August 2026, 904 of them in the latest 12 months.
Which brands appear most often?
Rotarex (1,331), JETSTREAM XC Atherectomy Catheter (741), Diamondback 360 Peripheral Orbital Atherectomy System (672), Jetstream Xc (590) and Hawkone 6fr (566). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.